OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib

This study explored drug transporter expression levels and their impact on clinical response to imatinib and second-generation tyrosine kinase inhibitors (TKIs) in imatinib- resistant chronic myeloid leukemia (CML). Imatinib-resistant chronic phase CML patients treated with dasatinib (n=10) and nilo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chonnam Med J
Main Authors: Kim, Yeo-Kyeoung, Lee, Seung-Shin, Jeong, Sung-Hoon, Ahn, Jae-Sook, Yang, Deok-Hwan, Lee, Je-Jung, Shin, Myung-Geun, Kim, Hyeoung-Joon
Formato: Artigo
Idioma:Inglês
Publicado em: Chonnam National University Medical School 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4276791/
https://ncbi.nlm.nih.gov/pubmed/25568846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2014.50.3.102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados